Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Can Dent Assoc ; 58(3): 201-2, 206-7, 1992 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-1532530

RESUMO

The treatment plan for the pediatric cardiac patient must include the following: 1. A complete medical history that will elicit adequate information with respect to the patient's possible heart condition. 2. Consultation with the family physician, pediatrician and/or cardiologist to learn the specific nature of the defect, specific past history, the child's ability to tolerate stress and anxiety, current medication and any specific recommendations for patient management. 3. Antibiotic prophylaxis, in an effort to prevent endocarditis, for all dental procedures that are likely to result in gingival bleeding, including routine professional cleaning. Application of chlorhexidine may be used as an adjunct to antibiotic prophylaxis, particularly in patients who are at high risk and/or with poor dental hygiene. 4. Prompt and vigorous treatment of all infections, with extraction to be considered as the preferred treatment for endodontically involved primary teeth. 5. A frank and open discussion with the parents and patient, detailing the importance of strict oral hygiene and regular dental care for both the oral and general health of the patient. As important as appropriate antibiotic prophylaxis is to the patient's continued health, it must be stated in summation that the dentist's efforts to foster optimal oral health are perhaps even more significant. Dental manipulation is in no way essential to the genesis of bacteremia, and it must be assumed that frequent showers of organisms are the rule in individuals who neglect their mouths. Perhaps the dentist performs the greatest service for this group when he or she succeeds in significantly modifying their oral hygiene behavior, thus preventing inadvertent septic "suicide".


Assuntos
Antibacterianos/uso terapêutico , Assistência Odontológica para a Pessoa com Deficiência , Endocardite Bacteriana/prevenção & controle , Cardiopatias Congênitas , Pré-Medicação , American Heart Association , Criança , Pré-Escolar , Humanos , Estados Unidos
2.
J Int Assoc Dent Child ; 20(2): 62-4, 1990 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2130106

RESUMO

Premature loss of teeth in posterior segments of the primary, mixed or permanent dentition may lead to space loss in an anterior-posterior dimension. This article illustrates how a simple, aesthetic and effective space maintainer can be used to prevent space loss in the permanent dentition.


Assuntos
Prótese Parcial Temporária , Mantenedor de Espaço em Ortodontia/métodos , Adolescente , Feminino , Humanos , Dente Molar , Aparelhos Ortodônticos , Mantenedor de Espaço em Ortodontia/instrumentação , Dente Impactado/prevenção & controle
3.
Radiology ; 140(3): 713-7, 1981 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7280240

RESUMO

Ioglucomide, a new iodinated nonionic contrast medium directed primarily toward myelographic use, was subjected to an extensive toxicological examination in animals. In the majority of studies, ioglucomide was compared directly with metrizamide. In some respects, including freedom from production of arachnoiditis, ioglucomide and metrizamide were comparable. However, acute toxicity after intravenous injection or instillation into cerebrospinal fluid was significantly less for ioglucomide. Also, in contrast to metrizamide, ioglucomide produced no evidence of any type of convulsive activity after subarachnoid administration. The improved safety of ioglucomide could not be related to osmolality; therefore, the importance of osmolality for nonionic myelographic agent safety is questioned.


Assuntos
Iodobenzoatos , Mielografia/métodos , Ácidos Tri-Iodobenzoicos , Animais , Encéfalo/efeitos dos fármacos , Meios de Contraste , Cães , Avaliação Pré-Clínica de Medicamentos , Estudos de Avaliação como Assunto , Injeções Intravenosas , Iodobenzoatos/administração & dosagem , Iodobenzoatos/efeitos adversos , Cinética , Dose Letal Mediana , Meninges/efeitos dos fármacos , Metrizamida/administração & dosagem , Metrizamida/efeitos adversos , Camundongos , Mielografia/efeitos adversos , Coelhos , Ratos , Ácidos Tri-Iodobenzoicos/administração & dosagem , Ácidos Tri-Iodobenzoicos/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...